Anti-Complement C3b-iC3b [5G9] Antibody
![Anti-Complement C3b-iC3b [5G9] Antibody](https://www.kerafast.com/MediaStorage/Product/Images/Large/1016_2001202001263110150.jpg "Anti-Complement C3b-iC3b [5G9] Antibody")
This mouse IgG2a monoclonal antibody [5G9] was generated against human C3b-sepharose and reacts with human and primate complement component 3b (C3b) and iC3b; blocks activation of the classical pathway of complement.
Highlights
- Reacts with both human and primate C3b and iC3b
- Blocks activation of the classical pathway of complement
- Suitable for Flow Cytometry and Neutralizing applications
The complement system consists of a number of small proteins found in the blood, generally synthesized by the liver, and normally circulating as inactive precursors (pro-proteins). When stimulated by one of several triggers, proteases in the system cleave specific proteins to release cytokines and initiate an amplifying cascade of further cleavages. The end-result of this activation cascade is massive amplification of the response and activation of the cell-killing membrane attack complex.
Complement component 3 (C3) plays a central role in the activation of the complement system. C3 cleavage by C3-convertase produces C3b and iC3b. C3b leads to an inflammatory response and also covalently binds to microbial cell surfaces aiding in opsonization of the microbe.
From the laboratory of Ronald P. Taylor, PhD, University of Virginia
Part of The Investigator's Annexe program.
This mouse IgG2a monoclonal antibody [5G9] was generated against human C3b-sepharose and reacts with human and primate complement component 3b (C3b) and iC3b; blocks activation of the classical pathway of complement.
Highlights
- Reacts with both human and primate C3b and iC3b
- Blocks activation of the classical pathway of complement
- Suitable for Flow Cytometry and Neutralizing applications
The complement system consists of a number of small proteins found in the blood, generally synthesized by the liver, and normally circulating as inactive precursors (pro-proteins). When stimulated by one of several triggers, proteases in the system cleave specific proteins to release cytokines and initiate an amplifying cascade of further cleavages. The end-result of this activation cascade is massive amplification of the response and activation of the cell-killing membrane attack complex.
Complement component 3 (C3) plays a central role in the activation of the complement system. C3 cleavage by C3-convertase produces C3b and iC3b. C3b leads to an inflammatory response and also covalently binds to microbial cell surfaces aiding in opsonization of the microbe.
From the laboratory of Ronald P. Taylor, PhD, University of Virginia
Part of The Investigator's Annexe program.
| Product Type: | Antibody |
| Antigen: | C3b |
| Accession ID: | P01024 |
| Isotype: | IgG2a |
| Clonality: | Monoclonal |
| Clone Name: | 5G9 |
| Reactivity: | Primate, Human |
| Immunogen: | Human C3b -Sepharose |
| Species Immunized: | Mouse |
| Epitope: | Human complement component 3b (C3b) and iC3b |
| Purification Method: | Protein G Affinity |
| Buffer: | 0.1M Sodium Phosphate, pH 7.4, 0.15M NaCl, 0.05% (w/v) Sodium Azide |
| Tested Applications: | Neutralizing and Flow Cytometry |
| Comments: | 5G9 blocks activation of the classical pathway of complement |
| Storage: | -20C |
| Shipped: | Cold packs |
- Lindorfer MA, Pawluczkowycz AW, Peek EM, Hickman K, Taylor RP, Parker CJ. A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement. Blood. 2010 Mar 18;115(11):2283-91.
- Beurskens FJ, Lindorfer MA, Farooqui M, Beum PV, Engelberts P, Mackus WJ, Parren PW, Wiestner A, Taylor RP. Exhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients. J Immunol. 2012 Apr 1;188(7):3532-41.
If you publish research with this product, please let us know so we can cite your paper.
